Can Cannabinoids Slow Ageing? Early Lab Evidence Is Intriguing, But Human Proof Remains Absent
Cannabinoids ageing preclinical evidence highlights CBD's role in autophagy induction and antioxidative system activation. Studies in nematodes show lifespan extension, but human data are lacking. This evidence is intriguing yet insufficient for clinical…
Cannabis Compounds Show Promise Against Cancer and Viral Disease—But the Evidence Is Still Largely Preclinical
This cannabis compounds medical evidence review summarizes recent research on cannabinoids in cancer and viral disease. While promising preclinical data exist, clinical evidence remains limited. The review clarifies where cannabis-derived therapies have…
CB2 Receptors in the Brain: A Promising but Unproven Anti-Inflammatory Target
CB2 receptor neuroinflammation is a promising target in neurodegenerative diseases such as Alzheimer's and Parkinson's. Preclinical studies show CB2 activation reduces brain inflammation and protects neurons. However, clinical evidence for CB2 receptor…
A Novel Adverse Outcome Pathway in Aluminum-Induced Male Infertility
Oxidative stress male infertility is a critical focus in understanding aluminum's reproductive toxicity. This study reveals how aluminum triggers endoplasmic reticulum stress and disrupts the endocannabinoid system. These findings provide new insights…
Activation of Cannabinoid Receptor 1 Enhances Wound Healing by Promoting the Proliferative Phase
Activation cannabinoid receptor type 1 plays a crucial role in wound healing by promoting the proliferative phase. This process involves increased fibroblast proliferation and enhanced extracellular matrix synthesis. Understanding this mechanism may…
Changes in Levels of Endocannabinoidome Mediators in Mice with Cancer Cachexia
Cancer cachexia involves significant changes in the endocannabinoid system cancer cachexia mediators, affecting metabolism and gut health. This study in mice reveals links between these mediators and steatosis as well as gut microbial dysbiosis.…
Repeated Administration of Cannabidiol Decreases Splenic Lymphocyte Subset Numbers in Rats
This study investigates CBD immunomodulatory effects, revealing decreased splenic lymphocyte subset numbers in rats after repeated administration. The findings highlight cannabidiol's impact on immune cell populations. Understanding these effects is…
Therapeutic Potential of Cannabidiol Supplementation in Mitigating Lipid Precursors of Inflammation in Hepatic Steatosis Progression
This study investigated cannabidiol lipid inflammation effects on early-stage hepatic steatosis progression. Cannabidiol supplementation may modulate lipid precursors of inflammation in liver disease. These findings highlight cannabidiol's potential role…
Time Course of THC Tolerance Development and Loss in Mice
This study investigates the THC tolerance development timeline focusing on hypothermia and locomotor activity effects in mice. It reveals rapid tolerance onset and recovery patterns after cessation. Understanding THC tolerance development timeline aids…
Cannabidiol (CBD) Does Not Reduce Cocaine Reward in Schizophrenia Model
CBD schizophrenia substance use effects were tested in a mouse model of genetic susceptibility. The study found no reduction in cocaine reward or self-administration. These findings suggest limited efficacy of CBD for treating substance use in…
